A share price of Vor Biopharma Inc [VOR] is currently trading at $10.01, up 2.67%. An important factor to consider is whether the stock is rising or falling in short-term value. The VOR shares have lost -46.47% over the last week, with a monthly amount drifted -65.55%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Vor Biopharma Inc [NASDAQ: VOR] stock has seen the most recent analyst activity on October 15, 2025, when Robert W. Baird upgraded its rating to a Outperform but kept the price target unchanged to $64 for it. Previously, Stifel upgraded its rating to Buy on September 24, 2025, and kept the price target unchanged to $55. On June 30, 2025, upgrade upgraded it’s rating to Buy but maintained its price target of $3 on the stock. Wedbush started tracking the stock assigning a Outperform rating and suggested a price target of $18 on July 26, 2022. Goldman initiated its recommendation with a Neutral and recommended $6 as its price target on April 27, 2022. H.C. Wainwright started tracking with a Buy rating for this stock on December 17, 2021, and assigned it a price target of $26. In a note dated December 03, 2021, Robert W. Baird initiated an Outperform rating and provided a target price of $38 on this stock.
Vor Biopharma Inc experienced fluctuations in its stock price throughout the past year between $2.62 and $65.80. Currently, Wall Street analysts expect the stock to reach $58 within the next 12 months. Vor Biopharma Inc [NASDAQ: VOR] shares were valued at $10.01 at the most recent close of the market. An investor can expect a potential return of 479.42% based on the average VOR price forecast.
Analyzing the VOR fundamentals
Gross Profit Margin for this corporation currently stands at 0.5% with Operating Profit Margin at -99.56%, Pretax Profit Margin comes in at -664.56%, and Net Profit Margin reading is -664.56%. To continue investigating profitability, this company’s Return on Assets is posted at -13.9, Equity is 2.75 and Total Capital is -2.33. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 9.56 points at the first support level, and at 9.10 for the second support level. However, for the 1st resistance point, the stock is sitting at 10.41, and for the 2nd resistance point, it is at 10.80.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Vor Biopharma Inc [NASDAQ:VOR] is 9.16. On the other hand, the Quick Ratio is 9.16, and the Cash Ratio is 8.52.
Transactions by insiders
Recent insider trading involved RA CAPITAL MANAGEMENT, L.P., Director, that happened on Oct 29 ’25 when 0.25 million shares were sold. Director, RA CAPITAL MANAGEMENT, L.P. completed a deal on Oct 28 ’25 to sell 0.12 million shares. Meanwhile, Director RA CAPITAL MANAGEMENT, L.P. sold 24579.0 shares on Oct 30 ’25.
